Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer.

The breast journal - 1 Jan 2000

Kim Sung, Rimm David, Carter Darryl, Khan Atif, Parisot Nicole, Franco Mayra Alvarez, Bale Allen, Haffty Bruce G

Abstract excerpt

Conservatively treated premenopausal breast cancer has a higher rate of local relapse as well as an increased genetic predisposition to cancer. The current study's purpose was to evaluate the interactions between BRCA-1/2 status and molecular biologic markers in a cohort of conservatively managed breast cancer patients. Seventy-six premenopausal women treated with breast-conserving surgery and radiation therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Premenopause

Share to Proliferating Cell Nuclear Antigen

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 12752624
DOI: 10.1046/j.1524-4741.2003.09307.x

Genes

PCNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer.PMID 12752624Read ↗

Conservative management of breast cancer in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.Semantic proximity Read ↗

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.Semantic proximity Read ↗

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?Semantic proximity Read ↗

Prognostic molecular markers in early breast cancerSemantic proximity Read ↗

Breast cancer immunohistochemical features in young women with BRCA 1/2 mutations.Semantic proximity Read ↗

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.Semantic proximity Read ↗

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>Semantic proximity Read ↗

Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profiling.Semantic proximity Read ↗

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.Semantic proximity Read ↗

Clinical significance of p53 and bcl-2 protein coexpression phenotypes in molecular breast cancer subtypes of pre-menopausal and post-menopausal African-American women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.